The FDA has approved the first generic equivalent of Climara Pro, offering a once-weekly transdermal option for managing moderate to severe vasomotor symptoms and preventing postmenopausal ...

A new liquid formulation of cevimeline HCl offers a bioequivalent alternative for adult patients experiencing dry mouth associated with Sjögren disease.

Strong recommendations made for semiannual surveillance for HCC, testing and vaccination for hepatitis A and B.

Dostarlimab-gxly demonstrated high rates of sustained clinical complete response that allowed eligible patients to avoid chemotherapy, radiation, and surgery.

The application for the next-generation mitomycin formulation is supported by 3-month complete response data from the phase 3 UTOPIA trial.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for rezafungin (Rezzayo ®) for the prophylaxis of invasive fungal disease.

Researchers found that mean serum potassium was 4.16 and 4.18mmol/L in the group assigned DASH-patterned groceries and the self-directed group, respectively.

The Food and Drug Administration (FDA) has expanded the approval of Ryzumvi ® (phentolamine ophthalmic solution 0.75%) to include the treatment of presbyopia in adults.

HealthDay News — Undeclared pharmacologically active ingredients (UPAIs) are detected in one-third of over-the-counter (OTC) skin products marketed online, according to a study published online ...

HealthDay News — Structured support may attenuate weight gain after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online October 7 in Obesity ...

The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.

The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief of eye redness due to minor irritation in individuals aged 12 years and ...